PDF - Presentation for Media & Analysts - Acino
PDF - Presentation for Media & Analysts - Acino
PDF - Presentation for Media & Analysts - Acino
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Acino</strong> Switzerland – launching<br />
products from own development<br />
Mepha/Cephalon acquisition facilitates access to new markets in MENA,<br />
Africa, Latin America & Asia and paved the way <strong>for</strong> launch of own product<br />
portfolio under the brand “<strong>Acino</strong> Switzerland”<br />
Status product launches:<br />
Launches of Clopacin® (clopidogrel besilate), Fentavera® (fentanyl patch),<br />
Metracin® (metoprolol succinate MUPS), Fuzocim® (alfuzosine-HCl); Doxacin®<br />
(doxazosin mesilate) and others are scheduled in several MENA & African markets<br />
First Asian launch of Clopacin® in H2-2012<br />
Latin America filings are under way; Clopacin® under fast track registration in<br />
Ecuador<br />
In addition a high number of product submissions in BtC markets<br />
38 already approved, additional 66 in registration<br />
Marketing and sales teams operate under the “<strong>Acino</strong> Switzerland” label<br />
Successful market new and re-entries<br />
26
Change language